Loading...
Market
What will be the next significant milestone for the brain-organoid-controlled robot by end of 2024?
2
Resolution / Starting Odds
Enhanced motor skills • 25%
Improved cognitive tasks • 25%
Integration with other AI systems • 25%
Other • 25%
Official announcements from the research team, verifiable news sources
Story
Chinese Scientists Develop Robot Controlled by Human Brain Organoid, Capable of Critical Tasks
Jul 8, 2024, 03:09 PM
Chinese scientists have developed a groundbreaking robot in China controlled by a brain organoid derived from human stem cells. The organoid communicates with the robot via a neural interface, which represents a significant advancement in brain-computer interface research. This robot is capable of performing critical tasks such as grasping objects, demonstrating the potential of integrating living brain cells with biocomputers to enhance robotic movement and functionality. This innovation could pave the way for future developments in robotics and artificial intelligence.
View original story
Similar markets
Commercial licensing • 25%
Peer-reviewed publication • 25%
Tech conference feature • 25%
Other • 25%
Enhanced mobility • 25%
Improved sensing capabilities • 25%
Longer operational lifespan • 25%
Other • 25%
Passes the Turing Test • 25%
Demonstrates complex manual tasks • 25%
Used in industrial applications • 25%
None of the above • 25%
New regulatory approval • 25%
New patient milestone • 25%
Commercial availability plans • 25%
New technological breakthrough • 25%
Surpasses human performance in a specific task • 25%
Achieves a breakthrough in natural language processing • 25%
Reaches a new level of general AI • 25%
Other • 25%
Increased accuracy above 99% • 25%
Wider commercial availability • 25%
Use in other neurological conditions • 25%
Other • 25%
Pass Turing Test • 25%
Perform complex task • 25%
Commercial sale • 25%
No significant milestone • 25%
Level 2: Reasoners • 25%
Level 3: Agents • 25%
Level 4: Innovators • 25%
Level 5: Organizations • 25%
Other • 25%
Improved accuracy over 99% • 25%
Reduced size and invasiveness • 25%
Extended functionality beyond speech • 25%
Discovery of a new neuro-target • 25%
Publication in a top-tier journal • 25%
FDA approval for a related treatment • 25%
Other • 25%
Plant • 25%
Animal • 25%
Fungus (other than mushroom) • 25%
Other • 25%
Level 2 • 25%
Level 3 • 25%
Level 4 • 25%
Level 5 • 25%